ETI
PFE icon

Enterprise Trust & Investment’s Pfizer PFE Stock Holding History

Enterprise Trust & Investment’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$4.36M Buy
83,056
+115
+0.1% +$5.86K 1.82% 15
2022
Q1 		$4.29M Hold
82,941
– – 1.54% 16
2021
Q4 		$4.9M Sell
82,941
-3,250
-4% -$161K 1.71% 13
2021
Q3 		$3.71M Hold
86,191
– – 1.5% 18
2021
Q2 		$3.38M Sell
86,191
-306
-0.4% -$11.9K 1.38% 21
2021
Q1 		$3.13M Buy
86,497
+10,368
+14% +$368K 1.4% 20
2020
Q4 		$2.83M Sell
76,129
-4,743
-6% -$174K 1.34% 21
2020
Q3 		$2.82M Sell
80,872
-2,003
-2% -$70.2K 1.58% 18
2020
Q2 		$2.57M Sell
82,875
-316
-0.4% -$10.7K 1.53% 20
2020
Q1 		$2.58M Sell
83,191
-580
-0.7% -$19.8K 1.81% 18
2019
Q4 		$3.11M Hold
83,771
– – 1.74% 18
2019
Q3 		$2.86M Sell
83,771
-18,843
-18% -$685K 1.75% 19
2019
Q2 		$4.22M Buy
+102,614
New +$4.07M 2.62% 9

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Enterprise Trust & Investment's PFE Position: Q2 2022 in Review

Enterprise Trust & Investment increased its Pfizer (PFE) stake by 0.14% in Q2 2022, buying an estimated $5.86K and bringing the position to 83,056 shares worth $4.36M. The position accounts for 1.82% of the portfolio, ranked #15.

Enterprise Trust & Investment first reported a position in PFE in Q2 2019 and has held it in 13 quarters since. The position peaked at $4.9M in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Enterprise Trust & Investment held 83,056 shares of Pfizer worth $4.36M as of Q2 2022.
  • Enterprise Trust & Investment bought 115 Pfizer shares in Q2 2022, an estimated $5.86K.
  • Pfizer made up 1.82% of Enterprise Trust & Investment's portfolio in Q2 2022, its #15 holding.
  • Enterprise Trust & Investment first reported a position in Pfizer in Q2 2019 and has held it in 13 quarters since.
  • Enterprise Trust & Investment's Pfizer position peaked at $4.9M in Q4 2021.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.